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Abstract
Background: we hypothesised that chronic widespread pain (CWP), by acting as a potential stressor, may predispose to the
development of, or worsening, frailty.
Setting: longitudinal analysis within the European Male Ageing Study (EMAS).
Participants: a total of 2,736 community-dwelling men aged 40–79.
Methods: subjects completed a pain questionnaire and shaded a manikin, with the presence of CWP deﬁned using the
American College of Rheumatology criteria. Physical activity, smoking, alcohol consumption and depression were measured.
Repeat assessments took place a median of 4.3 years later. A frailty index (FI) was used, with frail deﬁned as an FI >0.35. The
association between CWP at baseline and the new occurrence of frailty was examined using logistic regression; the association
between CWP at baseline and change in FI was examined using negative binomial regression.
Results: at baseline, 218 (8.3%) men reported CWP. Of the 2,631 men who were deﬁned as non-frail at baseline, 112 (4.3%)
were frail at follow-up; their mean FI was 0.12 (SD 0.1) at baseline and 0.15 (SD 0.1) at follow-up, with a mean change of 0.03
(SD 0.08) P ≤ 0.001. Among men who were non-frail at baseline, those with CWP were signiﬁcantly more likely to develop
frailty. After adjustment for age and centre, compared with those with no pain, those with CWP at baseline had a 70% higher
FI at follow-up; these associations remained signiﬁcant after further adjustment for smoking, body mass index, depression,
physical activity and FI at baseline.
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Conclusion: the presence of CWP is associated with an increased risk of frailty in older European men.
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Introduction
Frailty is a common geriatric syndrome that becomes more
prevalent with increasing age. Data pooled from 21 studies
indicate an overall prevalence estimate of 10.7% in commu-
nity-dwelling older adults [1]. There is no generally accepted
deﬁnition of frailty; however, it has been deﬁned as a ‘state of
increased vulnerability to poor resolution of homeostasis after
a stressor event, resulting from cumulative loss of physiological
reserve’ [2]. Those suffering from frailty have been found to
have an increased risk of hospitalisation and falls [3]. Factors
linked with the development and progression of frailty include
smoking, alcohol consumption and depression [4], obesity [5]
and the presence of chronic diseases such as cardiovascular
disease and diabetes [6]. Chronic widespread pain (CWP) is a
prominent symptom of ﬁbromyalgia, affecting up to 11% of
adult men and women [7] and it is linked with adverse health
outcomes including an increased mortality risk [8]. In this
study, the American College of Rheumatology (ACR) criteria
were used to identify those suffering from CWP [9]; subjects
had to have pain for a minimum of 3 months in both the left
and right sides of the body, above and below the waist and in
the axial skeleton. CWP appears to be fundamentally different
in its aetiology compared with more localised rheumatic or
osteoarthritic pains. Risk factors for CWP include psycho-
logical distress [10], poor sleep [11], low levels of physical
activity and being overweight [12, 13]. Perturbations in the
Hypothalamic–Pituitary–Adrenal axis have been linked with
the development of chronic pain [14], and we hypothesised
that CWP, by acting as a stressor, would be associated with an
increased risk of incident frailty. Previous studies provide
support for a link between pain and frailty, although they
have been unable to determine the direction of the observed
associations because of the cross-sectional nature of the data
[15, 16].
The aim of this analysis was to determine whether the oc-
currence of CWP predisposes middle-aged and older men to
the development of, or worsening, frailty.
Methods
Study design
Details regarding recruitment and study set-up have been
described elsewhere [17]. Brieﬂy, 3,369 community-dwelling
men aged 40–79 were recruited from population registers
in eight centres: Florence (Italy), Leuven (Belgium), Łódź
(Poland), Malmö (Sweden), Manchester (UK), Santiago de
Compostela (Spain), Szeged (Hungary) and Tartu (Estonia).
Subjects were mailed a study information pack, a short postal
questionnaire, and they attended a health screening at a local
research clinic. Of those who completed baseline assess-
ments, 86% (adjusted for mortality) completed the follow-up
assessments with a mean of 4.3 years (range 3.0–5.7 years;
SD = 0.3) after baseline data were collected [18]. All assess-
ments were carried out using standardised protocols. Ethical
approval for the study was obtained in accordance with local
institutional requirements in each centre. All subjects pro-
vided written informed consent.
Assessments
Postal questionnaire
The initial postal questionnaire captured demographic, health
and lifestyle information including smoking and alcohol con-
sumption. Subjects were also asked whether they were cur-
rently being treated for asthma, chronic bronchitis, adrenal
and/or prostate disease, epilepsy, peptic ulcer, thyroid
disease, heart, kidney and/or liver conditions, testicular and/
or pituitary disease, high blood pressure, diabetes, and if they
had ever suffered a stroke or been diagnosed with cancer.
Other assessments
Subjects who attended for assessment completed an
interviewer-assisted questionnaire that included the Beck’s
Depression Inventory-II (BDI-II) [19], the 36-Item Medical
Outcomes Study Survey (SF-36) [20] and the Physical
Activity Scale for the Elderly (PASE) [21]. Physical function
tests included the Reuben’s Physical Performance Test (PPT)
[22] and Tinetti’s balance and postural stability index [23].
Three neuropsychological tests were conducted to evaluate
cognitive function; these measured visuo-perceptual abilities,
executive function and memory [24], the recognition compo-
nent of visual memory retrieval [25] and cognitive processing
speed and visual scanning [26]. These assessments were
used to provide deﬁcits to make up the FI (Supplementary
data, Appendix 1, available in Age and Ageing online).
Anthropometric measurements included height, weight, mid
to upper arm circumference and triceps skin fold thickness.
Body mass index (BMI) was calculated as body weight (kg)
divided by the square of height (m2).
Frailty
An EMAS FI was developed comprising 39 deﬁcits that re-
present symptoms, signs or functional impairments that ac-
cumulate with age and are individually related to adverse
health outcomes [27]. The variables used fulﬁlled the require-
ments for the development of an FI; they related to health
status, increased with age, did not appear too early in life
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and covered a range of systems. The deﬁcits included co-
morbidities and cognitive functioning, as well as items from
the BDI-II, the SF-36, the PTT and the Tinetti index
(Supplementary data, Appendix 1 available in Age and Ageing
online). The same deﬁcits were used in the FI at baseline and
follow-up. Binary variables were re-coded; ‘0’ represented the
absence of and ‘1’ the presence of a deﬁcit. A value of ‘0.5’
was used for categorical variables that indicated an inter-
mediate response. Continuous variables were dichotomised
based on the 10th centile. The FI was calculated as the
number of health deﬁcits present in an individual divided
by the number of deﬁcits considered. The FI was categorised
using published criteria [28]; robust subjects had FI scores
<0.2, pre-frail subjects were 0.2–0.35 and frail subjects
were >0.35. The EMAS FI has been associated with an
increased risk of mortality [29] and impaired overall sexual
functioning [30].
Ascertainment of pain status
Subjects were asked if they had experienced ‘any pain which
lasted for one day or more’ in the past month. Those who
answered positively were then asked if their pain lasted
3 months or more and to indicate by shading a pain manikin.
Those satisfying the ACR criteria for CWP were identiﬁed.
Those participants who did report pain, but did not
meet these criteria, were classiﬁed as experiencing ‘some
pain’ and those who did not report any pain were classiﬁed
as experiencing ‘no pain’. Using this deﬁnition in EMAS,
CWP has previously been associated with poor mental
health, the presence of co-morbidities and recent adverse life
events [31].
Statistical methods
Analyses were conducted using STATA SE v13.1 (StataCorp,
College Station, TX, USA). Depending on distribution, para-
metric (paired t-tests) and non-parametric (Wilcoxon rank
sum) statistical approaches were used to describe differences
in baseline characteristics between those non-frail at baseline
and those who did or did not develop frailty at follow-up.
Logistic regression was used to determine the association
between CWP at baseline and the new occurrence of frailty.
To facilitate the longitudinal analysis, only subjects who were
either robust or pre-frail at baseline were included in these
models. Analyses were performed unadjusted, then adjusted
for baseline age and centre and subsequently for baseline
BMI, depression, smoking status and physical activity. The
results were expressed as odds ratios (OR) and 95% conﬁ-
dence intervals (CI). Negative binomial regression was used
to determine the association between CWP at baseline and
an increase in FI at follow-up, with the change in FI as the
dependent variable and CWP the main predictor. Negative
binomial regression is typically used to model over-dispersed
count variables. To facilitate this modelling approach, the FI
was ﬁrst multiplied by 100 to convert it to a scale from 0 to
100 (to yield integer values without changing the
distribution), with 0 representing no deﬁcits and 100
maximum deﬁcits. Analyses were performed unadjusted,
then adjusted for baseline age and centre, and subsequently
for baseline BMI, depression, smoking status, physical activ-
ity and FI. As two items of the BDI-II were included as deﬁ-
cits in the FI; assessing changes in sleeping patterns and
concentration; these were removed from the BDI-II score
before running the analysis in order to avoid spurious asso-
ciations being found. The results were reported as incident
rate ratios (IRR) and 95% CIs.
Results
Subjects
Of the 3,369 men who took part in EMAS, 2,736 subjects,
mean age 59.2 years (SD 10.6), had complete data to allow
FI characterisation at baseline and follow-up. The baseline
characteristics for these subjects are presented in Table 1.
The mean BMI was 27.7 kg/m2 (SD 4.0), 23.3% drank
alcohol on 5 or more days per week and 19.8% were current
smokers.
Change in frailty status
At baseline, 2,244 men were classiﬁed as robust, 387 men as
pre-frail and 105 as frail and at follow-up; 2,079 robust, 478
pre-frail and 179 frail. Of those, 2,631 men were non-frail at
baseline, 112 (4.3%) became frail at follow-up. The mean
score for the FI at baseline was 0.12 (SD 0.1) and at follow-
up was 0.15 (SD 0.1); the mean change was 0.03 (SD 0.08).
The distribution of the FI at baseline and follow-up is shown
in Supplementary data, Appendix 2, available in Age and
Ageing online. Complete description of frailty status by base-
line pain is shown in Supplementary data, Appendix 3, avail-
able in Age and Ageing online.
Determinants of incident frailty
Among the 2,631 men non-frail at baseline, compared with
those who did not develop frailty at follow-up, those who did
were older, had lower physical activity levels, were more likely
to be depressed, had a higher BMI and were more likely to
report experiencing CWP at baseline (21.7% versus 6.9%,
P≤ 0.001), see Table 1.
Pain status and frailty
Incident frailty
Table 2 shows the associations between baseline pain and in-
cident frailty at follow-up. After adjusting for age and centre,
compared with subjects who reported no pain, those who
reported some pain at baseline were more likely to have
developed frailty at follow-up (OR = 1.59; 95% CI 1.00,
2.55). Compared with those without pain, those with CWP
had an increased risk of frailty at follow-up (OR = 5.14; 95%
CI 2.82, 9.38). Further adjustment for baseline BMI,
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depression, smoking status and physical activity attenuated
the results; compared with those with no pain, those experi-
encing CWP at baseline were signiﬁcantly more likely to have
developed frailty at follow-up (OR = 4.32; 95% CI 2.21,
8.46).
Worsening frailty
After adjusting for age and centre, compared with subjects
who reported no pain, those who reported CWP at baseline
had an estimated 70% higher FI score at follow-up, and
those with some pain had a 30% higher FI score at follow-
up. After further adjustment for baseline BMI, depression,
and smoking status, physical activity and FI, the strength of
the association was attenuated though remained signiﬁcant.
Compared with subjects who reported no pain, those who
reported some pain, had an estimated 10%, and those who
reported CWP had an estimated 18% higher FI score at
follow-up, see Table 3. As there is a reported strong associ-
ation between CWP and sleep [10, 11], the data were
re-analysed after excluding an item of the BDI-II that related
to changes in sleeping patterns, which was used in the deriv-
ation of the FI; CWP remained predictive after adjusting for
age and centre (IRR = 1.68; 95% CI 1.51, 1.87) and after
adjusting further for baseline BMI, depression, smoking,
physical activity and baseline FI (IRR = 1.18; 95% CI 1.07,
1.30).
Discussion
In this prospective study, CWP was associated with the
development of, and also worsening, frailty as assessed using
an FI. This was independent of previously identiﬁed risk
factors such as smoking status, BMI and depressive
symptoms.
Our data are consistent with the ﬁndings from earlier
studies [15, 16]. In a cross-sectional study of 1,705 men aged
70 or older, an association was found between frailty, deﬁned
using the Cardiovascular Health Study criteria, and intrusive
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2. Baseline pain status and incident frailty: logistic regression analysis
Baseline characteristics Model 1 Model 2 Model 3
Odds ratios (95% confidence intervals)
Age (years) 1.10 (1.07, 1.12)** 1.10 (1.07, 1.13)**
Pain status
No pain Reference Reference Reference
Some pain 1.55 (0.98, 2.44) 1.59 (1.00, 2.55)* 1.46 (0.87, 2.45)
Chronic widespread pain 4.80 (2.72, 8.46)** 5.14 (2.82, 9.38)** 4.32 (2.21, 8.46)**
Body mass index (BMI) (kg/m2) 1.10 (1.04, 1.16)**
Depression (BDI) 1.11 (1.08, 1.15)**
Smoking (yes versus no) 2.52 (1.44, 4.42)**
Physical activity scale for the elderly 0.99 (0.98, 0.99)*
Model 1: unadjusted, n= 2,525; Model 2: adjusted for age and centre, n= 2,525; Model 3: adjusted for age, centre, BMI, smoking status, depression (continuous
variable minus items used in FI) and physical activity at baseline, n= 2,479.
*P≤ 0.05.
**P≤ 0.001.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Subject characteristics
Baseline variables All Robust or pre-frail,
both time points
Non-frail at baseline,
frail at follow-up
P value*
n Mean (SD) n Mean (SD) n Mean (SD)
Age (years) 2,736 59.2 (10.6) 2,519 58.4 (10.4) 112 67.4 (9.3) ≤0.001
Height (m) 2,712 174.0 (7.2) 2,499 174.3 (7.2) 112 171.1 (7.3) ≤0.001
Weight (kg) 2,706 83.9 (13.7) 2,492 83.6 (13.4) 112 86.2 (13.6) 0.02
Body mass index (kg/m2) 2,703 27.7 (4.0) 2,491 27.5 (3.9) 112 29.4 (3.9) ≤0.001
Physical activity scale for the elderly 2,540 200.1 (88.9) 2,338 205.1 (87.1) 102 156.4 (87.4) ≤0.001
Becks depression inventory (BDI-II) 2,736 6.5 (6.2) 2,519 5.9 (5.5) 112 11.0 (6.6) ≤0.001
BDI minus items used in frailty index 2,735 5.4 (5.5) 2,519 4.8 (4.9) 112 9.3 (6.1) ≤0.001
Number (%) Number (%) Number (%)
Alcohol intake (≥5 days/week) 2,725 634 (23.3) 2,509 615 (24.5) 112 12 (10.7) ≤0.001
Smoking status (current) 2,712 537 (19.8) 2,496 487 (19.5) 112 29 (25.9) 0.10
Pain status 2,624 2,419 106 ≤0.001
Pain free 1,094 (41.7) 1,051 (43.4) 30 (28.3)
Some pain 1,312 (50.0) 1,200 (49.6) 53 (50.0)
Chronic widespread pain 218 (8.3) 168 (6.9) 23 (21.7)
*Paired t-test or Wilcoxon signed-rank test depending on variables distribution; χ2 test for categorical variables.
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pain (determined using a question from the Short-form
12-item health survey: ‘During the past four weeks, how
much did pain interfere with your normal work—including
both work outside the home and housework?’), after adjust-
ment for demographic factors, number of co-morbidities
and arthritis [15]. In a cross-sectional study of 4,968 men and
women, moderate or greater levels of pain (assessed using a
5-point verbal descriptor scale: ‘How much bodily pain have
you had during the past 4 weeks?’) were found to be asso-
ciated with frailty, measured using self-report items from the
Canadian Study of Health and Ageing [16]. A key limitation
with these cross-sectional studies is their inability to deter-
mine the temporal nature of the association. Our longitudinal
data conﬁrm an association between a baseline assessment
of CWP and the subsequent development of, and worsening
of, frailty over 4.3 years of follow-up.
We can hypothesise possible mechanisms linking chronic
pain with the development of frailty. Chronic pain is asso-
ciated with a variety of adverse health factors including de-
pression and comorbidities. Karp et al. [32] argued that, due
to the multidimensional impact CWP has on older people, it
is plausible that it impacts on physiologic systems, reduces
reserve and decreases one’s ability to maintain homeostasis.
This view was supported by Shega et al. [16], who argued that
older adults with persistent pain and its associated condi-
tions, including lack of sleep and poor nutrition, may experi-
ence a decrease in their reserve, which increases the
likelihood of falls and cognitive dysfunction. The evidence
that perturbations in the stress-hormone axis are linked with
the development of CWP would be consistent with this [14].
The strength of the association found between pain and
frailty in the current study would appear to be stronger for
CWP than some pain. This may be explained by CWP
having more profound effects on a number of health out-
comes than regional/short-lived pain [33]. CWP is also
recognised by ACR as a meaningful clinical capture of severe
pain, whereas it is not clear what the measure for ‘some pain’
is capturing, which could suggest that there is a dose–re-
sponse relationship between pain and frailty.
Our ﬁndings are also consistent with earlier studies
reporting associations between frailty and a variety of health
and lifestyle factors. Hubbard and colleagues [34] reported
that heavy smokers (determined through self-report) were
the most frail (using an FI) compared with light and never
smokers. Blaum and colleagues [5] conducted a cross-
sectional analysis on 599 women aged 70–79 and found that
obesity (BMI ≥30 kg/m2) was associated with frailty
(deﬁned using a ‘frailty phenotype’ approach). Strawbridge
and colleagues [4] carried out analyses on prospective risk
factors that were measured in 574 subjects aged 65–102,
over three decades. Frailty was categorised based on whether
subjects had difﬁculties in two or more functional domains;
both smoking and depression were cumulative predictors of
frailty. Past research has also identiﬁed an association
between frailty and social deprivation [35] and future re-
search should take this into consideration when exploring the
association between pain and frailty.
Our study has unique positive features; the prospective
data were derived from a large population-based sample; a
standardised approach was taken to the conduct of the study
and established and validated measures were used to capture
CWP and frailty. There are limitations; the response rate for
participation at baseline was 41% with those who declined to
take part being older, more likely to be current smokers and
reporting experiencing less pain lasting at least 1 day in the
past month, than those who participated in the study [17].
Accordingly, the estimates of the occurrence of both frailty
and CWP at baseline may differ from the base populations
from which the subjects were recruited, and caution is
required in interpreting these absolute estimates. Similarly, a
number of men did not attend for the repeat survey; some
had died while others declined to participate. Given this, the
results relating to the absolute incidence of frailty need to be
interpreted with some caution. It seems unlikely that any
such selection factors would impact on the ﬁndings reported
here which were based on internal comparison of those who
took part. The data on CWP in this study were obtained by
self-report and a shaded manikin—it is possible that errors
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3. Baseline pain status and change in frailty index: negative binomial regression analysis
Baseline characteristics Model 1 Model 2 Model 3
Incident rate ratios (95% confidence intervals)
Age (years) 1.04 (1.03, 1.04)** 1.02 (1.02, 1.02)**
Pain status
No pain Reference Reference Reference
Some pain 1.30 (1.22, 1.40)** 1.30 (1.22, 1.38)** 1.10 (1.04, 1.15)**
Chronic wisespread pain 1.75 (1.55, 1.98)** 1.70 (1.52, 1.88)** 1.18 (1.08, 1.30)**
Body mass index (BMI) (kg/m2) 1.02 (1.01, 1.02)**
Depression (BDI-II) 1.02 (1.01, 1.02)**
Smoking (yes versus no) 1.18 (1.11, 1.26)**
Physical activity scale for the elderly 0.99 (0.99, 1.00)
Frailty index (baseline) 1.04 (1.03, 1.04)**
Model 1: unadjusted, n= 2,624; Model 2: adjusted for age and centre, n= 2,624; Model 3: adjusted for age, centre, BMI, smoking status, depression (continuous
variable minus items used in FI), physical activity and FI at baseline, n= 2,572.
**P ≤ 0.001.
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of recall or shading in the manikin may have resulted in some
misclassiﬁcation of exposure status (CWP); the effect of any
such misclassiﬁcation though would be to attenuate any real
biological association. Finally, the cohort studied comprised
predominantly Caucasian men, with a mean age of 59 years;
therefore, caution is needed when extrapolating the ﬁndings
beyond this group
In conclusion, CWP is associated with both incident, and
worsening frailty in middle-aged and older European men,
largely independent of health and lifestyle confounders. Our
ﬁndings not only suggest potential opportunities for targeted
interventions to reduce the occurrence of frailty, but also
highlight that clinicians need to be more attentive of the pain
status of older people. Further studies are needed to conﬁrm
our observations and identify the physiological mechanisms
underpinning this association.
Key points
• CWP was associated with worsening frailty among older
men, as assessed using an FI.
• This association was largely independent of various health
and lifestyle factors.
• The aetiology of the relationship between pain and frailty
requires further study.
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Abstract
Background and objective: C-reactive protein (CRP) is a widely used cardiovascular risk marker, but questions remain about
its role in the disability process in old age. This study examines the associations between CRP levels and physical performance
in old age in different societies.
Methods: data were collected during the baseline survey of IMIAS in 2012 in Kingston (Canada), Saint-Hyacinthe (Canada),
Manizales (Colombia) and Natal (Brazil). Approximately 200 men and 200 women aged 65–74 were recruited at each site.
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